Last update 08 May 2025

CD2 x CD3 x c-Met x EGFR

Basic Info

Related Targets
CD2CD3c-Met[+1]

Related

1
Drugs associated with CD2 x CD3 x c-Met x EGFR
QL-615
Target
CD2 x CD3 x EGFR x c-Met
Mechanism
CD2 agonists [+3]
Active Org.
Qlsf Biotherapeutic, Inc.Qlsf Biotherapeutic, Inc.
Originator Org.
Qlsf Biotherapeutic, Inc.Qlsf Biotherapeutic, Inc.
Active Indication
Solid tumor
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CD2 x CD3 x c-Met x EGFR
Login to view more data
100 Translational Medicine associated with CD2 x CD3 x c-Met x EGFR
Login to view more data
0 Patents (Medical) associated with CD2 x CD3 x c-Met x EGFR
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free